Senior Clinical Pharmacologist
Office of Clinical Evaluation, Office of Therapeutic Products, CBER/FDA
Silver Spring, Maryland
Million A. Tegenge is senior clinical pharmacologist at Office of Therapeutic Products (OTP), Center for Biologics Evaluation and Research (CBER). In addition to his primary clinical pharmacology review activities , Dr. Tegenge is invovled in scientific research, guidance and policy development in the area of model-informed drug development, biomarkers and immunogenicity. Dr. Tegenge started his FDA career in 2012 as a computational pharmacology/toxicology fellow and developed first-generation physiologically based pharmacokinetic models to assess the risk of a new class of vaccine adjuvants. Previously, Dr. Tegenge was a neurology postdoctoral fellow at the Johns Hopkins University School of Medicine. He received his Doctoral degree in Systems Neuroscience and a Master’s degree in Pharmaceutical Sciences.
Disclosure information not submitted.
Biomarkers of Rare Diseases for Cell and Gene Therapy Products
Monday, October 21, 2024
10:00 AM – 10:30 AM MT